Citigroup Inc Journey Medical Corp Transaction History
Citigroup Inc
- $196 Billion
- Q2 2025
A detailed history of Citigroup Inc transactions in Journey Medical Corp stock. As of the latest transaction made, Citigroup Inc holds 4,310 shares of DERM stock, worth $39,264. This represents 0.0% of its overall portfolio holdings.
Number of Shares
4,310Holding current value
$39,264% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding DERM
# of Institutions
63Shares Held
7.16MCall Options Held
0Put Options Held
0-
Tang Capital Management LLC San Diego, CA1.85MShares$16.9 Million0.8% of portfolio
-
Wasatch Advisors Inc Salt Lake City, UT1.15MShares$10.5 Million0.04% of portfolio
-
B. Riley Securities, Inc. Los Angeles, CA865KShares$7.88 Million0.36% of portfolio
-
Vanguard Group Inc Valley Forge, PA615KShares$5.6 Million0.0% of portfolio
-
Essex Investment Management CO LLC Boston, MA354KShares$3.23 Million0.44% of portfolio
About Journey Medical Corp
- Ticker DERM
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 11,596,500
- Market Cap $106M
- Description
- Journey Medical Corporation focuses on the development and commercialization of pharmaceutical products for the treatment of dermatological conditions in the United States. The company's marketed products include Qbrexza, a medicated cloth towelette for the treatment of primary axillary hyperhidrosis; Accutane, an oral isotretinoin drug to treat...